Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Wednesday, 21'st Aug 2024
Zacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond
05:00am, Sunday, 18'th Aug 2024
Healthcare and tech remain top areas for long-term investors. Vertex Pharmaceuticals is looking ahead to several near-term launches, while its existing portfolio remains robust.
3 Fantastic Growth Stocks to Buy in August
07:30am, Saturday, 17'th Aug 2024
Eli Lilly is a biopharma giant that could still deliver strong growth. Novo Nordisk's growth story isn't over thanks to Ozempic, Wegovy, and a promising pipeline.
BMY vs. VRTX: Which Stock Is the Better Value Option?
12:41pm, Thursday, 15'th Aug 2024
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Bristol Myers Squibb (BMY) or Vertex Pharmaceuticals (VRTX). But which of these two stocks is
Vertex (VRTX) Stock Outperforms Industry YTD: Here's Why
09:06am, Thursday, 15'th Aug 2024
Vertex's (VRTX) CF sales are expected to remain strong despite a slight slowdown in the growth rate. Casgevy and suzetrigine (if approved) are set to provide the necessary diversification from the CF
3 Biotech Stocks to Buy on the Dip: August 2024
06:00am, Thursday, 15'th Aug 2024
With the current market volatility, knowing which biotech stocks to buy on the dip can lead to lucrative returns as the industry is likely to recover faster than the market average. After all, many of
Prediction: These 4 Future Technologies Will Be Millionaire-Makers -- and Here Are the Top Stocks to Buy Now to Profit From Them
05:45am, Thursday, 15'th Aug 2024
Investors should focus on the future, not the past. Four emerging technologies hold tremendous potential.
2 Biotech Stocks To Watch In August 2024
08:36pm, Tuesday, 13'th Aug 2024
Biotech stocks to keep on your radar this month.
2 Biotech Stocks to Buy Hand Over Fist in August
09:30am, Monday, 12'th Aug 2024
Vertex's newest approval and late-stage pipeline should yield stronger financial results. Smaller biotech Sarepta Therapeutics continues to innovate in its core therapeutic area.
The Zacks Analyst Blog Vertex Pharmaceuticals CRISPR and Moderna
05:31am, Friday, 09'th Aug 2024
Vertex Pharmaceuticals CRISPR and Moderna are included in this Analyst Blog.
Here's How to Play Vertex (VRTX) Stock After Q2 Loss, Price Dip
12:11pm, Thursday, 08'th Aug 2024
Vertex (VRTX) is a great stock to have in one's portfolio based on its strong overall financial performance and robust pipeline progress.
The 3 Best Biotech Stocks to Buy in August 2024
06:30am, Thursday, 08'th Aug 2024
Amid the stock market turmoil, wagering on the best biotech stocks could be a savvy move. The stock market has been tumultuous lately, which could spur a pivot toward defensive biotech stocks.
Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England
07:12pm, Wednesday, 07'th Aug 2024
LONDON--(BUSINESS WIRE)--Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible transfusion-dependent beta thalassemia (TDT) patients to access t
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
10:01am, Tuesday, 06'th Aug 2024
Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
04:31am, Tuesday, 06'th Aug 2024
Vertex Pharmaceuticals is a rare-disease drugmaker with over $10 billion in annual sales. The company's lead drug is the only available treatment for cystic fibrosis, a life-threatening progressive di
